Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor W Li

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Addiction Medicine|January 9, 2025
Direct Induction of Buprenorphine Extended-Release: A Case ReportPouya Azar, James S H Wong, Jessica Machado, et al.
Journal of Psychoactive Drugs|November 19, 2024
24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-ReleasePouya Azar, Victor W Li, James S H Wong, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 11, 2024
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépressionVictor W Li, Jaspreet Sahota, Deea K Dev, et al.
Addiction Science & Clinical Practice|March 14, 2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart reviewPouya Azar, Victor W Li, Mohammadali Nikoo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Addiction Medicine|January 9, 2025
Direct Induction of Buprenorphine Extended-Release: A Case ReportPouya Azar, James S H Wong, Jessica Machado, et al.
Journal of Psychoactive Drugs|November 19, 2024
24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-ReleasePouya Azar, Victor W Li, James S H Wong, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 11, 2024
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépressionVictor W Li, Jaspreet Sahota, Deea K Dev, et al.
Addiction Science & Clinical Practice|March 14, 2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart reviewPouya Azar, Victor W Li, Mohammadali Nikoo, et al.
Pageof 2